226 results on '"O'Hara, Steven P."'
Search Results
2. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target
3. Addressing the Call to Increase High School Students' STEM Awareness through a Collaborative Event Hosted by Science and Education Faculty: A How-to Approach
4. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis
5. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the Mdr2-/- mouse
6. Cellular senescence in the cholangiopathies
7. Correction to: Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target
8. The transcription factor ETS1 promotes apoptosis resistance of senescent cholangiocytes by epigenetically up-regulating the apoptosis suppressor BCL2L1
9. Cellular senescence in the cholangiopathies
10. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice
11. Localized Glucose and Water Influx Facilitates Cryptosporidium parvum Cellular Invasion by Means of Modulation of Host-Cell Membrane Protrusion
12. ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A
13. Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes
14. Immunology of Cryptosporidiosis
15. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis
16. Host Cell Actin Remodeling in Response to Cryptosporidium
17. Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography
18. The dynamic biliary epithelia: Molecules, pathways, and disease
19. Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
20. TLR4 PROMOTES CRYPTOSPORIDIUM PARVUM CLEARANCE IN A MOUSE MODEL OF BILIARY CRYPTOSPORIDIOSIS
21. HIV-1 Tat Protein Suppresses Cholangiocyte Toll-like Receptor 4 Expression and Defense against Cryptosporidium parvum
22. Cholangiocyte N-Ras Protein Mediates Lipopolysaccharide-induced Interleukin 6 Secretion and Proliferation
23. The cell biology of cryptosporidium infection
24. Portal fibroblasts: A renewable source of liver myofibroblasts
25. MicroRNAs in Cholangiopathies
26. Distribution of Cryptosporidium parvum Sporozoite Apical Organelles during Attachment to and Internalization by Cultured Biliary Epithelial Cells
27. The enteric microbiome in hepatobiliary health and disease
28. NFκB p50-CCAAT/Enhancer-binding Protein β (C/EBPβ)-mediated Transcriptional Repression of MicroRNA let-7i following Microbial Infection
29. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
30. MicroRNAs: Key Modulators of Posttranscriptional Gene Expression
31. MicroRNA regulation of innate immune responses in epithelial cells
32. Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation
33. A Cellular Micro-RNA, let-7i, Regulates Toll-like Receptor 4 Expression and Contributes to Cholangiocyte Immune Responses against Cryptosporidium parvum Infection
34. Accumulation of tropomyosin isoform 5 at the infection sites of host cells during Cryptosporidium invasion
35. Immunology of Cryptosporidiosis
36. A novel Cryptosporidium parvum antigen, CP2, preferentially associates with membranous structures
37. Localized glucose and water influx facilitates Cryptosporidium parvurn cellular invasion by means of modulation of host-cell membrane protrusion
38. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor
39. The immunobiology of cholangiocytes
40. Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation.
41. Portal fibroblasts: A renewable source of liver myofibroblasts.
42. The Gut‐Liver Axis in Primary Sclerosing Cholangitis: Are Pathobionts the Missing Link?
43. Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2−/−) mice
44. Cellular senescence, neuropeptides and hepatic fibrosis: Additional insights into increasing complexity
45. Role of the Intestinal Microbiome in Cholestatic Liver Disease
46. The enteric microbiome in hepatobiliary health and disease
47. Erratum: Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes
48. Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
49. Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR)
50. Microbiome‐immune interactions and liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.